Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Placebo-controlled, 2-Injection, 52-Week Study to Evaluate the Efficacy and Safety of Intra-articular Injections of CNTX-4975-05 in Subjects With Chronic, Moderate-to-severe Osteoarthritis Knee Pain
Conditions
Interventions
Placebo
CNTX-4975-05
Locations
30
United States
Holland Center for Family Health
Glendale, Arizona, United States
GB Family Care
Phoenix, Arizona, United States
Arizona Research Center
Phoenix, Arizona, United States
Med Center Medical Clinic
Carmichael, California, United States
TriWest Research Associates
El Cajon, California, United States
Arthritis Care and Research Center, Inc. (ACRC Studies)
Poway, California, United States
Start Date
September 9, 2018
Primary Completion Date
June 11, 2020
Completion Date
June 11, 2020
Last Updated
July 21, 2022
NCT07364578
NCT06488144
NCT07058623
NCT06083480
NCT06955481
NCT06208631
Lead Sponsor
Centrexion Therapeutics
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions